Effect of vitamin D therapy on endothelial function in ischemic heart disease female patients with vitamin D deficiency or insufficiency: A primary report

Abstract

BACKGROUND: Vitamin D deficiency is associated with vascular endothelial dysfunction. We evaluated endothelial function in ischemic heart disease (IHD) patients with vitamin D deficiency or insufficiency before and after vitamin D therapy. METHODS: An uncontrolled before-after study was conducted in Isfahan, Iran on consecutive sample of female IHD patients who had undergone percutaneous coronary intervention in the preceding 6 months and/or referred with chronic stable angina. Forty patients with vitamin D deficiency or insufficiency (serum 25-hydroxy vitamin D &lt; 20 or 20-30 ng/ml, respectively) were included and received two intramuscular injections of 300,000 IU cholecalciferol with 1 month interval. Endothelial function, assessed by measuring flow-mediated dilatation (FMD), and serum 25-hydroxy vitamin D level were measured at baseline and 1 month after the second dose of cholecalciferol. RESULTS: A total of 30 patients completed the study, age = 59.4 &plusmn; 8.7 years; serum 25-hydroxy vitamin D = 19.0 &plusmn; 6.5 ng/ml. After treatment, serum 25-hydroxy vitamin D was reached to &gt; 30 ng/ml in all patients. Brachial artery diameter (mm) after ischemia increased significantly, statistically but not clinically (4.55 &plusmn; 0.37 to 4.67 &plusmn; 0.38, P &lt; 0.001). Furthermore, FMD (%) was increased from 1.96 &plusmn; 1.65 to 4.65 &plusmn; 1.27 (P &lt; 0.001). The amount of change in FMD was not significantly correlated with serum 25-hydroxy vitamin D (r = 0.038, P = 0.858). CONCLUSION: Endothelial function was improved after vitamin D therapy in IHD patients with low serum vitamin D. Controlled studies with larger sample size are required to confirm if vitamin D therapy has effects on endothelial function. &nbsp;&nbsp;</div